Production (Stage)
Minerva Neurosciences, Inc.
NERV
$1.84
$0.052.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -7.84% | 17.22% | 154.55% | 100.53% | 48.08% |
| Gross Profit | 7.84% | -17.22% | -154.55% | -100.53% | -48.08% |
| SG&A Expenses | -2.53% | -4.46% | 0.19% | -0.28% | -0.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.02% | -5.50% | 16.56% | 30.11% | 8.24% |
| Operating Income | 22.02% | 5.50% | -16.56% | -30.11% | -8.24% |
| Income Before Tax | 119.79% | 104.80% | 88.05% | -25.59% | -7.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 119.79% | 104.80% | 88.05% | -25.59% | -7.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 119.79% | 104.80% | 88.05% | -25.59% | -7.81% |
| EBIT | 22.02% | 5.50% | -16.56% | -30.11% | -8.24% |
| EBITDA | 22.02% | 5.50% | -53.62% | -165.62% | -357.20% |
| EPS Basic | 118.44% | 104.08% | 90.73% | 10.75% | 18.38% |
| Normalized Basic EPS | 118.44% | 104.08% | 90.73% | 10.75% | 18.37% |
| EPS Diluted | 118.34% | 103.99% | 90.62% | 10.73% | 18.36% |
| Normalized Diluted EPS | 118.44% | 104.08% | 90.73% | 10.75% | 18.37% |
| Average Basic Shares Outstanding | 7.29% | 16.49% | 27.42% | 40.61% | 32.10% |
| Average Diluted Shares Outstanding | 7.29% | 16.49% | 27.42% | 40.61% | 32.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |